Inventor · disambiguated record
Joerg Zielonka
Also filed as: ZIELONKA JOERG
4 granted patents·6 pending applications·15 citations·filing 2016–2025
67Inventor score
Files withHOFFMANN LA ROCHE10
Top patents by PatentIndex Score
10 records- 0193US11242396B2Bispecific antigen binding molecules comprising anti-FAP clone 212HOFFMANN LA ROCHE·Filed 2019·Granted Feb 8, 2022·14 cites·36 claims
- 0282US11780919B2Bispecific antigen binding molecules targeting OX40 and FAPHOFFMANN LA ROCHE·Filed 2021·Granted Oct 10, 2023·1 cites·24 claims
- 0373US12275794B2Bispecific antigen binding molecules comprising anti-FAP clone 212HOFFMANN LA ROCHE·Filed 2021·Granted Apr 15, 2025·0 cites·27 claims
- 0473US2024117049A1Bispecific antigen binding molecules targeting ox40 and fapHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0570US2023227584A1Bispecific antibodies comprising a modified c-terminal crossfab fragmentHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0670US2025320305A1Bispecific antigen binding molecules comprising anti-fap clone 212HOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0769US2023355754A1Combination therapy of tumor targeted icos agonists with t-cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0857US2020306373A1Combination therapy of tumor targeted icos agonists with t-cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0956US2022098305A1Novel icos antibodies and tumor-targeted antigen binding molecules comprising themHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1042US11536716B2Cell based assay for determining antibody or ligand binding and functionHOFFMANN LA ROCHE·Filed 2016·Granted Dec 27, 2022·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Joerg Zielonka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →